FDA Inspection 1232490 — Adventist HealthCare Shady Grove Medical Center
The FDA completed an inspection of Adventist HealthCare Shady Grove Medical Center on Feb 22, 2024 in Rockville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 22, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Rockville, MD (United States)